跳至主要内容
临床试验/NL-OMON43594
NL-OMON43594已完成不适用

Ga-68-DOTA-RGD2 PET/CT in patients with head and neck cancer: a potential tracer to image angiogenesis in tumors. - PET/CT imaging with Ga-68-DOTA-RGD2 in HNSCC

Department of Radiology and Nuclear Medicine0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Proven HNSSC of the oral cavity, oro- and hypopharynx, or larynx
  • - At least one lesion with a diameter of at least 1.5 cm
  • - A diagnostic CT or MRI scan is obtained within 4 weeks prior to screenings visit
  • - Planned surgery as primary treatment
  • - * 18 years
  • - Ability to provide written informed consent

排除标准

  • - Contra-indications for PET: pregnancy, breast-feeding, or severe claustrophobia
  • - Abnormal renal function
  • * creatinine clearance * 60 mL/min according to the formula of Cockroft and Gault
  • - Abnormal liver function
  • * ALAT or ASAT level more than 3 times the upper limit of normal range
  • * Bilirubin more than 2 times the upper limit of normal range
  • - Other serious illness

研究者

发起方
Department of Radiology and Nuclear Medicine

相似试验

Ga-68-DOTA-RGD2 PET/CT in patients with head and... | 临床试验